Endothelial Dysfunction as a Component of Severe Acute Respiratory Syndrome Coronavirus 2-Related Multisystem Inflammatory Syndrome in Children With Shock.
Adrenal Cortex Hormones
/ therapeutic use
Angiopoietin-2
/ blood
Biomarkers
C-Reactive Protein
/ analysis
COVID-19
/ complications
Cardiotonic Agents
/ therapeutic use
Child
Female
Humans
Immunoglobulins
/ therapeutic use
Intensive Care Units, Pediatric
Interleukin-6
/ blood
Lactic Acid
/ blood
Male
Respiration, Artificial
Retrospective Studies
SARS-CoV-2
Severity of Illness Index
Shock
/ pathology
Shock, Cardiogenic
/ pathology
Systemic Inflammatory Response Syndrome
/ drug therapy
Troponin
/ blood
Vasoconstrictor Agents
/ therapeutic use
Ventricular Function, Left
COVID-19 Drug Treatment
Journal
Critical care medicine
ISSN: 1530-0293
Titre abrégé: Crit Care Med
Pays: United States
ID NLM: 0355501
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
pubmed:
29
5
2021
medline:
27
10
2021
entrez:
28
5
2021
Statut:
ppublish
Résumé
NCT04420468. Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children is frequently associated with shock; endothelial involvement may be one of the underlying mechanisms. We sought to describe endothelial dysfunction during multisystem inflammatory syndrome in children with shock and then assess the relationship between the degree of endothelial involvement and the severity of shock. Observational study. A PICU in a tertiary hospital. Patients aged under 18 (n = 28) with severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children and shock, according to the Centers for Disease Control and Prevention criteria. None. Correlations between endothelial marker levels and shock severity were assessed using Spearman coefficient. The median (interquartile range) age was 9 years (7.5-11.2 yr). Sixteen children presented with cardiogenic and distributive shock, 10 presented with cardiogenic shock only, and two presented with distributive shock only. The median left ventricular ejection fraction, troponin level, and lactate level were, respectively, 40% (35-45%), 261 ng/mL (131-390 ng/mL), and 3.2 mmol/L (2-4.2 mmol/L). Twenty-five children received inotropes and/or vasopressors; the median Vasoactive and Inotropic Score was 8 (5-28). Plasma levels of angiopoietin-2 (6,426 pg/mL [2,814-11,836 pg/mL]), sE-selectin (130,405 pg/mL [92,987-192,499 pg/mL]), von Willebrand factor antigen (344% [288-378%]), and the angiopoietin-2/angiopoietin-1 ratio (1.111 [0.472-1.524]) were elevated and significantly correlated with the Vasoactive and Inotropic Score (r = 0.45, p = 0.016; r = 0.53, p = 0.04; r = 0.46, p = 0.013; and r = 0.46, p = 0.012, respectively). Endothelial dysfunction is associated with severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children with shock and may constitute one of the underlying mechanisms.
Identifiants
pubmed: 34049308
doi: 10.1097/CCM.0000000000005093
pii: 00003246-202111000-00023
pmc: PMC8507588
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Angiopoietin-2
0
Biomarkers
0
Cardiotonic Agents
0
Immunoglobulins
0
Interleukin-6
0
Troponin
0
Vasoconstrictor Agents
0
Lactic Acid
33X04XA5AT
C-Reactive Protein
9007-41-4
Banques de données
ClinicalTrials.gov
['NCT04420468']
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1151-e1156Informations de copyright
Copyright © 2021 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Déclaration de conflit d'intérêts
Dr. Borgel’s institution received funding from Leo PHARMA and ROCHE Financial. The remaining authors have disclosed that they do not have any potential conflicts of interest.
Références
Rowley AH, Shulman ST, Arditi M. Immune pathogenesis of COVID-19-related multisystem inflammatory syndrome in children. J Clin Invest. 2020; 130:5619–5621
Belot A, Antona D, Renolleau S, et al. SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020. Euro Surveill. 2020; 25
Blondiaux E, Parisot P, Redheuil A, et al. Cardiac MRI of children with multisystem inflammatory syndrome associated with COVID-19. Radiology. 2020; 297:E283–E288
Johansson PI, Stensballe J, Ostrowski SR. Shock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism. Crit Care. 2017; 21:25
Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 2020; 69:1181–1189
Fox SE, Lameira FS, Rinker EB, et al. Cardiac endotheliitis and multisystem inflammatory syndrome after COVID-19. Ann Intern Med. 2020; 173:1025–1027
CDC. Multisystem Inflammatory Syndrome in Children (MIS-C) [Internet]. Centers for Disease Control and Prevention, 2020. Accessed July 14, 2020. Available at: https://www.cdc.gov/mis-c/
Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005; 6:2–8
Brissaud O, Botte A, Cambonie G, et al. Experts’ recommendations for the management of cardiogenic shock in children. Ann Intensive Care. 2016; 6:14
Walker SB, Conlon TW, Zhang B, et al. Clinical signs to categorize shock and target vasoactive medications in warm versus cold pediatric septic shock. Pediatr Crit Care Med. 2020; 21:1051–1058
McIntosh AM, Tong S, Deakyne SJ, et al. Validation of the vasoactive-inotropic score in pediatric sepsis*. Pediatr Crit Care Med. 2017; 18:750–757
Richter RP, Russell RT, Hu PJ, et al. Plasma angiopoietin-2/-1 ratio is elevated and angiopoietin-2 levels correlate with plasma syndecan-1 following pediatric trauma. Shock. 2019; 52:340–346
Whitney JE, Zhang B, Koterba N, et al. Systemic endothelial activation is associated with early acute respiratory distress syndrome in children with extrapulmonary sepsis. Crit Care Med. 2020; 48:344–352
Smadja DM, Guerin CL, Chocron R, et al. Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients. Angiogenesis. 2020; 23:611–620
Melendez E, Whitney JE, Norton JS, et al. Systemic angiopoietin-1/2 dysregulation in pediatric sepsis and septic shock. Int J Med Sci. 2019; 16:318–323
Breunis WB, Davila S, Shimizu C, et al.; International Kawasaki Disease Genetics Consortium. Disruption of vascular homeostasis in patients with Kawasaki disease: Involvement of vascular endothelial growth factor and angiopoietins. Arthritis Rheum. 2012; 64:306–315
Joffre J, Hellman J, Ince C, et al. Endothelial responses in sepsis. Am J Respir Crit Care Med. 2020; 202:361–370
Ostrowski SR, Gaïni S, Pedersen C, et al. Sympathoadrenal activation and endothelial damage in patients with varying degrees of acute infectious disease: An observational study. J Crit Care. 2015; 30:90–96
Lemaire LC, de Kruif MD, Giebelen IA, et al. Dobutamine does not influence inflammatory pathways during human endotoxemia. Crit Care Med. 2006; 34:1365–1371
White M, Ducharme A, Ibrahim R, et al. Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: Improvement after short-term inotropic support. Clin Sci (Lond). 2006; 110:483–489